+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Diabetes Global Market-Forecast to 2026

  • ID: 4895390
  • Report
  • January 2020
  • Region: Global
  • 403 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
The Devices Global Market is Expected to Grow at a Mid Single CAGR From 2019 to 2026

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • BodyTel GmbH
  • Emperra Diabetes Care
  • Glytec LLC
  • MEDISANA
  • Sirma Medical Systems
  • MORE

Digital diabetes includes products utilizing advanced technologies for monitoring, managing and tools that help in deciding optimum therapy options in the patients suffering from diabetes. These devices help in monitoring of blood sugar levels, calorie counting, and in insulin dose calculation, reduce complications to improve the quality of life of diabetics. According to analysis, digital diabetes global market expected to reach $16,329.6 million by 2026 growing at a high single digit CAGR from 2019 to 2026.

The digital diabetes global market is segmented based on products, end-users and geography.
The product market is further segmented into devices and apps and software. As estimated by the publisher, the devices global market is expected to grow at a mid single CAGR from 2019 to 2026. The apps and software global market is expected to grow at a strong double digit CAGR from 2019 to 2026 due to growing adoption of digital solutions such as cloud based software, technology advancements such as incorporating artificial intelligence to manage the diabetes are driving the market. However, privacy and data safety issues, stringent regulatory approvals, lack of reimbursement are restraining the market growth.

The digital diabetes devices global market by product type is segmented into SBGM, CGM, Smart Insulin Pumps, and Smart Insulin Pens.
CGM accounted for the largest market revenue in 2019 and is expected to grow at a double digit CAGR from 2019 to 2026 due to increasing number of regulatory approvals for CGM systems; technological advancements in devices and other pipeline devices. SBGM products are further segmented into Smart Blood glucose meter, Blood glucose testing-strips, Lancets and control solution. Blood glucose testing-strips accounted largest revenue in 2019. CGM products are further segmented into glucose sensors and transmitter and receiver. Glucose sensor commanded the largest revenue in 2019 and is expected to grow at a double digit CAGR due to increasing adoption of CGM systems, development of advanced CGM systems, and favourable government policies in developed countries promoting the adoption of CGM systems. The smart insulin pump products are further segmented into traditional insulin pump and patch pump. Traditional insulin pump held the largest revenue in 2019 and expected to grow at a mid single digit CAGR from 2019 to 2026 and Patch pump is expected to grow at a double digit CAGR from 2019 to 2026.

The Digital diabetes end-user market is segmented into home care, hospitals & private clinics and others which include ambulatory setting, academic and research institutes.
Homecare accounted for largest revenue in 2019. The largest revenue of this segment can be mainly attributed to technological advancements and a shift toward home care and self-management of diabetes, an increase in prevalence of diabetes disease, the improvement and acceptance of home care devices has increased. In addition, the growing focus of companies to increase awareness about diabetes and glucose management devices & apps are further driving the adoption in home care settings. Homecare is the fastest growing segment with projected high single digit CAGR from 2019 to 2026 due to the increase of self management of diabetes using apps and software at home itself.

Geographical wise, the North America region commanded the largest revenue in 2019 and expected to grow at a mid single digit CAGR from 2019 to 2026.
Some of the driving factors are increased awareness of the benefits of using continuous glucose monitoring systems, growing diffusion of smart devices, increasing prevalence and incidences of diabetes due to obesity and better accessibility to technologies compared to other regions and presence of well-established distribution channels of the major players in this region. However, Asia-Pacific region is expected to grow at a double digit strong CAGR from 2019 to 2026 due to a large pool of patients with diabetes, increasing patient awareness about diabetes, and increasing affordability of advanced treatment due to increasing prosperity.

The digital diabetes global market is a competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares and also acquiring companies for product expansion. Some of the key players in the digital diabetes global market are Abbott Laboratories (U.S.), Dexcom, Inc. (U.S.), Insulet Corporation (U.S.), i-Sens, Inc (South Korea), Livongo Health, Inc. (U.S.), Medtronic PLC (Ireland), F.Hoffmann-LA Roche AG (Switzerland), Senseonics Holdings Inc. (U.S.), Tandem Diabetes Care (U.S.), and Ypsomed Holding AG (Switzerland).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America (U.S. and Rest of N.A.)
  • Europe (Germany, France, Italy and Rest of E.U.)
  • Asia-Pacific  (Japan, China, India and Rest of APAC)
  • Rest of the World (RoW) (Brazil, Rest of Latin-America and Middle East & Others)
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • BodyTel GmbH
  • Emperra Diabetes Care
  • Glytec LLC
  • MEDISANA
  • Sirma Medical Systems
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope Of The Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown And Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points From Secondary Sources
2.6.6 Key Data Points From Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 The Global Rise In The Prevalence And Incidence Of Diabetes
3.3.1.2 Technological Advancements In Digital Diabetes Devices
3.3.1.3 Growing Diffusion Of Smart Devices And Digital Platforms
3.3.1.4 Increasing R & D Investments
3.3.2 Restrains And Threats
3.3.2.1 High Cost Associated With The Products
3.3.2.2 Product Recalls
3.3.2.3 Inadequate Reimbursement
3.3.2.4 Strict Regulation Of Glucose Monitoring Devices By Regulatory Organizations Like The Fda And Others
3.3.2.5 Privacy Concern And Safety Issues In Digital Diabetes
3.4 Market Share Analysis
3.4.1 Digital Diabetes Global Market Share Analysis
3.4.2 Continuous Glucose Monitor (Cgm) Market Share Analysis
3.4.3 Smart Insulin Pump Market Share Analysis
3.5 Regulatory Affairs
3.5.1 U.S.
3.5.2 Europe
3.5.3 China
3.5.4 India
3.5.5 Japan
3.6 Technological Advancements
3.6.1 Artificial Intelligence And Machine Learning
3.7 Clinical Trials
3.8 Funding Scenario
3.9 Digital Diabetes – Deals, Approvals And New Product Launch
3.10 Approval
3.11 Fda And Ce Approved Diabetes Management Apps
3.12 Product Launch
3.13 Revenue Model
3.13.1 Introduction
3.13.2 Freemium Model
3.13.3 Third Party Payment Model
3.13.4 Different Revenue Streams Model
3.13.5 Lower Pricing Model
3.13.6 New Payment Model Or New Pricing Model
3.14 Porter’S Five Force Analysis
3.14.1 Threat Of New Entrants
3.14.2 Threat Of Substitutes
3.14.3 Bargaining Power Of Suppliers
3.14.4 Bargaining Power Of Buyers
3.14.5 Rivalry Among Existing Competitors
3.15 Patent Analysis
3.16 Units Sold
3.16.1 Glucose Testing Strips Units Sold
3.16.2 Cgm Sensors Units Sold
3.16.3 Smart Insulin Pump Units Sold
3.16.4 Smart Insulin Pen Units Sold
3.17 Market Penetration

4 Digital Diabetes Global Market, By Products
4.1 Introduction
4.2 Devices
4.2.1 Smart Blood Glucose Monitoring(Sbgm)
4.2.1.1 Smart Blood Glucose Meter
4.2.1.2 Blood Glucose Testing Strips
4.2.1.3 Lancets
4.2.1.4 Others
4.2.2 Continuous Glucose Monitoring (Cgm)
4.2.2.1 Glucose Sensors
4.2.2.2 Transmitter And Receivers
4.2.3 Smart Insulin Pump
4.2.3.1 Traditional Insulin Pump
4.2.3.2 Patch Insulin Pump
4.2.4 Smart Insulin Pen
4.3 Apps And Software

5 Digital Diabetes Global Market, By End-Users
5.1 Introduction
5.2 Home Care
5.3 Hospitals And Private Clinics
5.4 Others

6 Regional Analysis
6.1 Introduction
6.2 North America
6.2.1 U.S.
6.2.2 Rest Of N.A.
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 Italy
6.3.4 Rest Of Europe
6.4 Asia - Pacific
6.4.1 Japan
6.4.2 China
6.4.3 India
6.4.4 Rest Of Apac
6.5 Rest Of The World
6.5.1 Brazil
6.5.2 Rest Of Latin America
6.5.3 Middle East & Others

7 Competitive Landscape
7.1 Introduction
7.2 Collaboration, Agreements And Partnerships
7.3 Approvals
7.4 New Product Launch
7.5 Acquisition
7.6 Expansion
7.7 Other Developments

8 Major Player Profiles
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Financials
8.1.3 Product Portfolio
8.1.4 Key Developments
8.1.5 Business Strategy
8.1.6 Swot Analysis
8.2 Dexcom, Inc
8.2.1 Overview
8.2.2 Financials
8.2.3 Product Portfolio
8.2.4 Key Developments
8.2.5 Business Strategy
8.2.6 Swot Analysis
8.3 F. Hoffmann-La Roche Ag.
8.3.1 Overview
8.3.2 Financials
8.3.3 Product Portfolio
8.3.4 Key Developments
8.3.5 Business Strategy
8.3.6 Swot Analysis
8.4 Insulet Corporation
8.4.1 Overview
8.4.2 Financials
8.4.3 Product Portfolio
8.4.4 Key Developments
8.4.5 Business Strategy
8.4.6 Swot Analysis
8.5 I-Sens, Inc.
8.5.1 Overview
8.5.2 Financials
8.5.3 Key Developments
8.5.4 Product Portfolio
8.5.5 Business Strategy
8.5.6 Swot Analysis
8.6 Livongo Health, Inc.
8.6.1 Overview
8.6.2 Financials
8.6.3 Key Developments
8.6.4 Product Portfolio
8.6.5 Business Strategy
8.6.6 Swot Analysis
8.7 Medtronic, Plc
8.7.1 Overview
8.7.2 Financials
8.7.3 Product Portfolio
8.7.4 Key Developments
8.7.5 Business Strategy
8.7.6 Swot Analysis
8.8 Senseonics Holdings, Inc.
8.8.1 Overview
8.8.2 Financials
8.8.3 Product Portfolio
8.8.4 Key Developments
8.8.5 Business Strategy
8.8.6 Swot Analysis
8.9 Tandem Diabetes Care Inc.
8.9.1 Overview
8.9.2 Financials
8.9.3 Product Portfolio
8.9.4 Key Developments
8.9.5 Business Strategy
8.9.6 Swot Analysis
8.10 Ypsomed Holding Ag.
8.10.1 Overview
8.10.2 Financials
8.10.3 Product Portfolio
8.10.4 Key Developments
8.10.5 Business Strategy
8.10.6 Swot Analysis

List Of Tables

Table 1 Digital Diabetes Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 2 Self-Monitoring Glucose Testing Strips Global Units Sold, By Region, (2018-2026) (No’S)
Table 3 Cgm Sensors Global Units Sold, By Region, (2018-2026) (N0’S)
Table 4 Smart Insulin Pump Global Units Sold, By Region, (2018-2026) (No’S)
Table 5 Smart Insulin Pen Global Units Sold, By Region, (2018-2026) (No’S)
Table 6 Digital Diabetes Global Market Revenue, By Products, (2018-2026) ($Mn)
Table 7 Digital Diabetes Devices Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 8 Digital Diabetes Devices Global Market Revenue, By Product Type, (2018-2026) ($Mn)
Table 9 Sbgm Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 10 Smart Blood Glucose Monitoring Global Market Revenue, By Products, (2018-2026) ($Mn)
Table 11 Smart Blood Glucose Meter Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 12 Blood Glucose Testing Strips Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 13 Lancets Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 14 Others Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 15 Cgm Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 16 Continuous Glucose Monitoring Global Market Revenue, By Products, (2018-2026) ($Mn)
Table 17 Cgm Glucose Sensors Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 18 Transmitter And Receiver Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 19 Smart Insulin Pump Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 20 Smart Insulin Pump Global Market Revenue, By Product Type, (2018-2026) ($Mn)
Table 21 Traditional Insulin Pump Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 22 Patch Insulin Pump Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 23 Smart Insulin Pen Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 24 Apps And Software Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 25 Digital Diabetes Global Market Revenue, By End-User, (2018-2026) ($Mn)
Table 26 Digital Diabetes Homecare Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 27 Digital Diabetes Hospital & Private Clinics Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 28 Digital Diabetes Others Global Market Revenue, By Region, (2018-2026) ($Mn)
Table 29 Digital Diabetes Global Market Revenue, By Region (2018 - 2026) ($Mn)
Table 30 North America Digital Diabetes Market Revenue, By Products (2018-2026) ($Mn)
Table 31 North America Digital Diabetes Devices Market Revenue, By Product Type (2018-2026) ($Mn)
Table 32 North-America Sbgm Market Revenue, By Products, (2018-2026) ($Mn)
Table 33 North America Continuous Glucose Monitoring Market Revenue, By Products (2018-2026) ($Mn)
Table 34 North America Smart Insulin Pump Market Revenue, By Product Type (2018-2026) ($Mn)
Table 35 North America Digital Diabetes Market Revenue, By End-User (2018-2026) ($Mn)
Table 36 North America Digital Diabetes Market Revenue, By Country (2018-2026) ($Mn)
Table 37 Europe Digital Diabetes Market Revenue, By Products (2018-2026) ($Mn)
Table 38 Europe Digital Diabetes Devices Market Revenue, By Product Type (2018-2026) ($Mn)
Table 39 Europe Sbgm Market Revenue, By Produts, (2018-2026)($Mn)
Table 40 Europe Continuous Glucose Monitoring Market Revenue, By Products (2018-2026) ($Mn)
Table 41 Europe Smart Insulin Pump Market Revenue, By Product Type (2018-2026) ($Mn)
Table 42 Europe Digital Diabetes Market Revenue, By End-User (2018-2026) ($Mn)
Table 43 Europe Digital Diabetes Market Revenue, By Country (2018-2026) ($Mn)
Table 44 Apac Digital Diabetes Market Revenue, By Products (2018-2026) ($Mn)
Table 45 Apac Digital Diabetes Devices Market Revenue, By Product Type (2018-2026) ($Mn)
Table 46 Apac Sbgm Market Revenue, By Products, (2018-2026) ($Mn)
Table 47 Apac Continuous Glucose Monitoring Market Revenue, By Products (2018-2026) ($Mn)
Table 48 Apac Smart Insulin Pump Market Revenue, By Product Type (2018-2026) ($Mn)
Table 49 Apac Digital Diabetes Market Revenue, By End-User (2018-2026) ($Mn)
Table 50 Apac Digital Diabetes Market Revenue, By Country (2018-2026) ($Mn)
Table 51 Row Digital Diabetes Market Revenue, By Products (2018-2026) ($Mn)
Table 52 Row Digital Diabetes Devices Market Revenue, By Product Type (2018-2026) ($Mn)
Table 53 Row Sbgm Market Revenue, By Products, (2018-2026) ($Mn)
Table 54 Row Continuous Glucose Monitoring Market Revenue, By Products (2018-2026) ($Mn)
Table 55 Row Smart Insulin Pump Market Revenue, By Product Type (2018-2026) ($Mn)
Table 56 Row Digital Diabetes Market Revenue, By End-User (2018-2026) ($Mn)
Table 57 Row Digital Diabetes Market Revenue, By Country (2018-2026) ($Mn)
Table 58 Approvals
Table 59 New Product Launch
Table 60 Acquisition
Table 61 Expansion
Table 62 Other Developments
Table 63 Abbott Laboratories, Inc: Total Revenue And R&D Expenses, (2017-2019)(Q3) ($Mn)
Table 64 Abbott Laboratories, Inc: Total Revenue, By Segments, (2017-2019) (Q3) ($Mn)
Table 65 Abbott Laboratories, Inc: Total Revenue, By Geography, (2017-2019) (Q3) ($Mn)
Table 66 Dexcom, Inc: Total Revenue And R&D Expenses (2017-2019) (Q3) ($Mn)
Table 67 Dexcom Inc: Total Revenue, By Segments (2017-2019) (Q3) ($Mn)
Table 68 Dexcom Inc: Total Revenue, By Geography (2017-2019) (Q3) ($Mn)
Table 69 F.Hoffmann-La Roche Ag: Total Revenue And R&D Expenses, (2017-2019) (Q3) ($Mn)
Table 70 F.Hoffmann-La Roche Ag: Total Revenue By Segments, (2017-2019) (Q3) ($Mn)
Table 71 F.Hoffmann-La Roche Ag: Diagnostics Revenue, By Segment, (2017-2019) (Q3) ($Mn)
Table 72 F.Hoffmann-La Roche Ag: Diabetes Care Revenue, By Geography, (2017-2019) (Q3) ($Mn)
Table 73 Roche Holdings Ag: Total Revenue, By Geography,(2017-2019) (Q3) ($Mn)
Table 74 Insulet Corporation: Total Revenue And R&D Expenses, (2017-2019) (Q3) ($Mn)
Table 75 Insulet Corporation: Total Revenue, By Segments, (2017-2019) (Q3) ($Mn)
Table 76 Insulet Corporation: Total Revenue, By Geography (2017-2019) (Q3) ($Mn)
Table 77 Livongo Health, Inc. : Total Revenue And R&D Expenses, (2017-2019) (Q3) ($Mn)
Table 78 Medtronic, Plc: Total Revenue And R&D Expenses, (2017-2019) (Q2) ($Mn)
Table 79 Medtronic, Plc: Total Revenue, By Segments,(2017-2019) (Q2) ($Mn)
Table 80 Medtronic, Plc: Total Revenue, By Geography, (2017-2019) (Q2) ($Mn)
Table 81 Senseonics Holdings, Inc.: Total Revenue And R&D Expenses, (2017-2019) (Q3) ($Mn)
Table 82 Senseonics Holdings, Inc.: Total Revenue, By Geography (2017-2019) (Q3) ($Mn)
Table 83 Tandem Diabetes Care, Inc.: Total Revenue And R&D Expenses, (2017-2019) (Q3) ($Mn)
Table 84 Tandem Diabetes Care, Inc.: Total Revenue, By Segments, (2017-2019) (Q3) ($Mn)
Table 85 Tandem Diabetes Care, Inc.: Total Revenue, By Geography (2017-2019) (Q3) ($Mn)
Table 86 Ypsomed Holding Ag: Total Revenue And R&D Expenses, (2017-2019) (Q2) ($Mn)
Table 87 Ypsomed Holding Ag: Total Revenue, By Segments, (2017-2019) (Q2) ($Mn)
Table 88 Ypsomed Holding Ag: Total Revenue, By Geography (2017-2019)(Q2) ($Mn)

List Of Figures

Figure 1 Digital Diabetes Global Market Revenue, By Region (2018-2026) ($Mn)
Figure 2 Research Methodology: Digital Diabetes Global Market
Figure 3 Digital Diabetes Global Market: Top-Down And Bottom-Up Approach
Figure 4 Digital Diabetes Global Market: Forecasting Model
Figure 5 Digital Diabetes Global Market: Market Breakdown & Data Triangulation
Figure 6 Digital Diabetes Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Digital Diabetes Global Market Share, By Major Players (2019) (%)
Figure 9 Digital Diabetes Global Cgm Market Share, By Major Players (2019) (%)
Figure 10 Smart Insulin Pump Global Market Share, By Major Players (2019) (%)
Figure 11 Digital Diabetes Market: Porter’S Analysis
Figure 12 Digital Diabetes Global Market: Patent Filing, By Major Players (2015-2019)
Figure 13 Self Monitoring Glucose Test Strips Global Units Sold, By Region And Countrywise (2019) (No’S)
Figure 14 Cgm Sensors Global Units Sold, By Region And Countrywise (2019) (No’S)
Figure 15 Smart Insulin Pump Global Units Sold, By Region And Countrywise (2019) (No’S)
Figure 16 Smart Insulin Pen Global Units Sold, By Region And Countrywise (2019) (No’S)
Figure 17 Smart Insulin Pens Market Penetration, (2019)
Figure 18 Smart Insulin Pump Market Penetration, (2019)
Figure 19 Digital Diabetes Global Market Share, By Products (2019 Vs 2026) (%)
Figure 20 Digital Diabetes Devices Global Market Share, By Region (2019 Vs 2026) (%)
Figure 21 Digital Diabetes Devices Global Market Share, By Product Type (2019 Vs 2026) (%)
Figure 22 Sbgm Global Market Share, By Region (2019 Vs 2026) (%)
Figure 23 Smart Blood Glucose Monitoring Global Market Share, By Products (2019 Vs 2026) (%)
Figure 24 Smart Blood Glucose Meter Market Share, By Region (2019 Vs 2026) (%)
Figure 25 Blood Glucose Testing Strips Market Share, By Region (2019 Vs 2026) (%)
Figure 26 Lancets Global Market Share, By Region (2019 Vs 2026) (%)
Figure 27 Others Global Market Share, By Region (2019 Vs 2026) (%)
Figure 28 Continuous Glucose Monitoring Global Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 29 Smart Insulin Pump Global Market Share, By Region (2019 Vs 2026) (%)
Figure 30 Smart Insulin Pump Global Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 31 Patch Insulin Pump Global Market Share, By Region (2019 Vs 2026) (%)
Figure 32 Smart Insulin Pen Global Market Share, By Region (2019 Vs 2026) (%)
Figure 33 Apps And Software Global Market Share, By Region (2019 Vs 2026) (%)
Figure 34 Digital Diabetes Global Market Share, By End-User (2019 Vs 2026) (%)
Figure 35 Digital Diabetes Homecare Global Market Share, By Region (2019 Vs 2026) (%)
Figure 36 Digital Diabetes Hospital And Private Clinics Global Market Share, By Region (2019 Vs 2026) (%)
Figure 37 Digital Diabetes Others Global Market Share, By Region (2019 Vs 2026) (%)
Figure 38 Digital Diabetes Global Market Revenue, By Region (2018 - 2026) ($Mn)
Figure 39 North America Digital Diabetes Market Share, By Products (2019 Vs 2026) (%)
Figure 40 North America Digital Diabetes Devices Market Share, By Product Type (2019 Vs 2026) (%)
Figure 41 North America Sbgm Market Share, By Products (2019 Vs 2026) (%)
Figure 42 North America Cgm Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 43 North America Smart Insulin Pump Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 44 North America Digital Diabetes Market Share, By End-User (2019 Vs 2026) (%)
Figure 45 North America Digital Diabetes Market Share, By Country (2019 Vs 2026) (%)
Figure 46 N.A. Smart Insulin Pump And Smart Insulin Pen Market Penetration, (2019)
Figure 47 U.S. Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 48 U.S. Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 49 U.S. Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 50 Rest Of N.A. Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 51 Rest Of N.A. Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 52 Rest Of N.A. Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 53 Europe Digital Diabetes Market Share, By Products (2019 Vs 2026) (%)
Figure 54 Europe Digital Diabetes Devices Market Share, By Product Type (2019 Vs 2026) (%)
Figure 55 Europe Sbgm Market Share, By Products (2019 Vs 2026) (%)
Figure 56 Europe Continuous Glucose Monitoring Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 57 Europe Smart Insulin Pump Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 58 Europe Digital Diabetes Market Share, By End-User (2019 Vs 2026) (%)
Figure 59 Europe Digital Diabetes Market Share, By Country (2019 Vs 2026) (%)
Figure 60 Europe Smart Insulin Pumps And Smart Insulin Pen Market Penetration, (2019)
Figure 61 Germany Digital Diabetes Market Revenue, By Product, (2019 Vs 2026) ($Mn)
Figure 62 Germany Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 63 Germany Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 64 France Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 65 France Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 66 France Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 67 Italy Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 68 Italy Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 69 Italy Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 70 Rest Of E.U. Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 71 Rest Of E.U. Digital Diabetes Devices Market Revenue, By Product-Type (2019 Vs 2026) ($Mn)
Figure 72 Rest Of E.U Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 73 Apac Digital Diabetes Market Share, By Products (2019 Vs 2026) (%)
Figure 74 Apac Digital Diabetes Devices Market Share, By Product Type (2019 Vs 2026) (%)
Figure 75 Apac Sbgm Market Share, By Products (2019 Vs 2026) (%)
Figure 76 Apac Continuous Glucose Monitoring Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 77 Apac Smart Insulin Pump Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 78 Apac Digital Diabetes Market Share, By End-User (2019 Vs 2026) (%)
Figure 79 Apac Digital Diabetes Market Share, By Country (2019 Vs 2026) (%)
Figure 80 Apac Smart Insulin Pumps And Smart Insulin Pens Market Penetration, (2019)
Figure 81 Japan Digital Diabetes Market Revenue, By Products, (2019 Vs 2026) ($Mn)
Figure 82 Japan Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 83 Japan Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 84 China Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 85 China Digital Diabetes Devices Market Share, By Product Type (2019 Vs 2026) ($Mn)
Figure 86 China Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 87 India Digital Diabetes Market Revenue, By Products, (2019 Vs 2026) ($Mn)
Figure 88 India Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 89 India Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 90 Rest Of Apac Digital Diabetes Market Revenue, By Products, (2019 Vs 2026) ($Mn)
Figure 91 Rest Of Apac Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 92 Rest Of Apac Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 93 Row Digital Diabetes Market Share, By Products (2019 Vs 2026) (%)
Figure 94 Row Digital Diabetes Devices Market Share, By Product Type (2019 Vs 2026) (%)
Figure 95 Row Sbgm Market Share, By Products (2019 Vs 2026) (%)
Figure 96 Row Continuous Glucose Monitoring Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 97 Row Smart Insulin Pump Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 98 Row Digital Diabetes Market Share, By End-User (2019 Vs 2026) (%)
Figure 99 Row Digital Diabetes Market Share, By Country (2019 Vs 2026) (%)
Figure 100 Row Smart Insulin Pumps And Smart Insulin Pens Market Penetration, (2019)
Figure 101 Brazil Digital Diabetes Market Revenue, By Products, (2019 Vs 2026) ($Mn)
Figure 102 Brazil Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 103 Brazil Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 104 Rest Of Latin America Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 105 Rest Of Latin America Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 106 Rest Of Latin America Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 107 Middle East & Others Digital Diabetes Market Revenue, By Products (2019 Vs 2026) ($Mn)
Figure 108 Middle East & Others Digital Diabetes Devices Market Revenue, By Product Type (2019 Vs 2026) ($Mn)
Figure 109 Middle East & Others Digital Diabetes Market Revenue, By End-User (2019 Vs 2026) ($Mn)
Figure 110 Key Growth Strategies (2018-2019)
Figure 111 Swot: Abbott Laboratories
Figure 112 Swot: Dexcom, Inc.
Figure 113 Swot: F.Hoffman-La Roche Ag
Figure 114 Swot: Insulet Corporation
Figure 115 Swot: I-Sens Inc.
Figure 116 Swot: Livongo Health, Inc.
Figure 117 Swot: Medtronic, Plc
Figure 118 Swot: Senseonics Holdings, Inc.
Figure 119 Swot: Tandem Diabetes Care
Figure 120 Swot: Ypsomed Holding Ag

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • A. Menarini Diagnostics
  • BodyTel GmbH
  • Emperra Diabetes Care
  • Glytec LLC
  • MEDISANA
  • Sirma Medical Systems
  • MORE

Digital diabetes includes products utilizing advanced technologies for monitoring, managingand tools that help in deciding optimum therapy options in the patients suffering fromdiabetes. These devices help in monitoring of blood sugar levels, calorie counting, and ininsulin dose calculation, reduce complications to improve the quality of life of diabetics. According to analysis, digital diabetes global market is expected to reach $16,329.6million by 2026. The factors such as global rise in the prevalence and incidence of diabetes,and technological advancement in digital diabetes devices are driving the market growth.The growing diffusion of smart devices and digital platforms and increasing R&D investmentsare providing opportunities for growth. Whereas, high cost associated with the products,increasing product recall and inadequate reimbursements are restraining the market growth.The threat for the digital diabetes market includes strict regulations from various regulatoryorganizations across geographies, safety issues and privacy concerns.  

Digital diabetes global market is segmented based on products, end-users and region.Product category is segmented into devices, apps and software. As estimated, the devices segment accounted for the largest revenue in 2019 and projected togrow at mid single digit CAGR from 2019 to 2026 due to increasing incidence andprevalence of diabetes, growing adoption of smart devices.

In the digital diabetes end-user market, homecare segment accounted for the largest sharein 2019 and this market is expected to grow at a high single digit CAGR from 2019 to 2026,this can be mainly attributed to technological advancements, shift towards self-managementof diabetes, the improvement and acceptance of home care devices. In addition, growingfocus of companies to increase awareness about diabetes andmanagement devices & appsare further driving the adoption in home care settings.  

Among various geographic market segments, North America region commanded the largestrevenue in 2019 growing at a mid single CAGR from 2019 to 2026. Increased awareness ofthe benefits of using continuous glucose monitoring systems, growing diffusion of smartdevices, and high incidences of obesity as well as diabetes are driving the market. However,Asia-Pacific region is expected to grow at double digit CAGR from 2019 to 2026 due toincreasing patient awareness, increasing prevalence of diabetes cases due to unhealthylifestyle, poor diet, excess alcohol consumption and increase in penetration of digital platform.

Approvals, agreements and acquisitions are driving the digital diabetes market growth. For instance, in October 2019, Dexcom, inc. received FDA approval for Dexcom G6 Pro a CGMsystem meant for healthcare specialists to assess the suitability for CGM therapy, ages twoyears and up. It is the first and only single use, professional CGM that gathers real-timeglucose data over a 10 day period and offers both a blinded and unblinded mode. Similarly,In October 2019 LifeScan entered into collaboration with Willis Towers Watson to expand theadoption of OneTouch Reveal plus, the digital diabetes therapeutic powered by Welldoc’saward winning BlueStar Platform.

Considering the attractiveness of digital diabetes market, several venture capitalists areaggressively investing in developing devices, apps and digital programs. According to analysis, funding received by digital diabetes companies during the period 2018-2019 wasworth $XX million. The funding is utilized to help pregnant woman at risk of developing Type2 diabetes and expansion of digital care programs and expansion of biosensor patch forCGM and also to develop hybrid closed loop automated insulin delivery app. For example inSeptember 2019, Liva Healthcare received $XX million funding from EU Horizon to helppregnant woman at risk of Type 2 diabetes. Digital diabetes clinical trials data indicateglobally, XX% are in phase 2 and XX% are in phase 3. Majority of clinical trials are focusedon developing smart insulin pump and artificial pancreas such as hybrid closed loop devices.  Major players in the digital diabetes global market are Abbott Laboratories (U.S.), Dexcom,Inc. (U.S.), Insulet Corporation (U.S.), i-Sens, Inc. (South Korea), Livongo Health, Inc. (U.S.), Medtronic PLC (Ireland), F.Hoffmann-LA Roche AG (Switzerland), Senseonics Holdings, Inc. (U.S.), Tandem Diabetes Care (U.S.), and Ypsomed Holding AG (Switzerland). 

Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Agamatrix Inc.
  • AirStrip Technologies
  • A. Menarini Diagnostics
  • Amalgam Rx, Inc.
  • Ambrosia System Inc
  • Apex Biotechnology corporation
  • Artelus
  • Arkray Inc.
  • Ascensia Diabetes Care Holdings AG
  • Azumio
  • B.Braun Melsungen AG
  • Beato
  • Becton, Dickinson & Company
  • BetaChek
  • Biochemical Systems International
  • Bioland Technology
  • Bionime Corporation
  • BioTelemetry Inc
  • Biotest Medical Corporation
  • Beurer GmbH
  • Beijing Dnurse Technologies Co.,Ltd.
  • BodyTel GmbH
  • Brigham and Women's Hospital
  • Brighter AB
  • Carematrix, Inc.
  • ChironX
  • Companion Medical Inc
  • DarIoHealth Corporation
  • Debiotech S.A.
  • Dexcom, Inc.
  • Diabeloop S.A.
  • Diabnext
  • Diafyt MedTech
  • Diamesco
  • Digital Medics Pty Ltd
  • Dottli
  • DreaMed Diabetes Ltd
  • Eli Lilly and Co.
  • Emperra Diabetes Care
  • EmsiG GmbH Co.
  • Entra Health systems
  • EOFlow
  • F.Hoffmann-La Roche AG
  • FIA Biomed GmbH
  • Fitscript LLC
  • Fooducate
  • Foracare, Inc.
  • Gendius
  • Genesis Health Technology
  • Glooko, Inc.
  • GlucoMe
  • Glucostratus Ltd
  • GlySens Incorporated
  • GlySure Limited
  • Glytec LLC
  • Greiner Bio-one
  • H2 Inc(Health2Sync)
  • Healthify Me
  • Heniz Herenz Medizinalbedarf GmbH
  • IDEAL LIFE INC.
  • i-Health Lab Inc.
  • IME-DC GmbH
  • Informed Data System Inc (One Drop)
  • Insulclock
  • Insulet Corporation
  • Intuity Medical, Inc
  • i-sens, Inc.
  • IXensor Company Ltd.
  • Jiangsu Delfu Medical Device Co.,Ltd
  • Jiangsu Huida Medical Instruments Co., Ltd
  • Koninklijike Philips B.V.
  • L-Tac Medicare
  • Livongo Health, Inc.
  • Lobeck Medical AG
  • MEDISANA
  • Medtronic PLC
  • Medtrum Technologies, Inc.
  • NovoNordisk
  • Nu-beca & maxcellent Co.
  • OK Biotech Co., Ltd
  • Osang Health care co ltd
  • Owen Mumford
  • Pepex Biomedical, Inc.
  • Pharma Tech Solutions, Inc.
  • Philosys inc
  • Platinum equity (Life scan inc)
  • POPS Diabetes Care Inc
  • Prodigy Diabetes Care, LLC
  • Saify Traders
  • Sanofi S.A.
  • Sarstedt
  • SD Biosensor
  • Senseonics Holdings, Inc.
  • Sensyne Health
  • Sirma Medical Systems
  • SMART Meter LLC
  • Social Diabetes, S.L.
  • Sooil Development Co., Ltd
  • Spike
  • Sweetch
  • TaiDoc Technology Corporation
  • Tandem Diabetes care
  • Tianjin Empecs Medical Device Co.,Ltd.
  • TidePool
  • Terumo Corporation
  • Trividea Health, Inc
  • Tyson bioresearch inc
  • UT Southwestern Medical Center
  • Valeritas Inc.
  • ViCentra B.V.
  • VirtaHealth Corp
  • VivaChek Laboratories, Inc.
  • Voluntis
  • WellDoc, Inc.
  • Wellspan Health
  • Ypsomed Holding AG
  • Zhejiang POCTech Co.,Ltd
Note: Product cover images may vary from those shown
Adroll
adroll